Philippines approves GMO golden rice for commercial production
By Staff,
GMWatch
| 07. 23. 2021
No independent health risk assessment was done; Farmer-scientist group MASIPAG condemns decision
The Philippines has approved GMO golden rice for commercial production. This is in spite of the fact that no independent data on the safety of this GMO for health and the environment have been published; that beta-carotene, which the rice is engineered to contain, is one of the commonest molecules in nature and numerous native plants contain high levels; and that the US FDA says that GMO golden rice doesn't contain enough beta-carotene to justify a health claim.
As Glenn Davis Stone and Dominic Glover point out, it is still unknown if the beta-carotene in GMO golden rice can even be converted to Vitamin A in the bodies of badly undernourished children. In addition, research shows that what beta-carotene there is in the rice degrades rapidly in storage. Cooking further degrades the beta-carotene.
Meanwhile, as the development of golden rice creeps along, the Philippines has managed to slash the incidence of Vitamin A deficiency by non-GMO methods.
The author of the France24 article below is clearly ignorant of these crucial facts.
1. Philippines approves GMO 'golden rice'...
Related Articles
By Joy Zhang, Progress Educational Trust | 08.12.2024
What do China's new ethical guidlines tell us about the country's changing attitude to human genome editing? Professor Joy Zhang reads between the lines...
Recently, China's National Science and Technology Ethics Committee introduced a new set of ethics guidelines on...
By Priyanka Runwal, Chemical and Engineering News | 08.05.2024
Saritee Sanodiya, 26, has spent countless days wondering if she’ll ever live a “normal” life. Growing up, Sanodiya often missed school, frequenting the hospital for sudden, life-threatening drops in her hemoglobin levels and excruciating pain in her joints. High fever...
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Alcott Wei, South China Morning Post | 07.13.2024
China has banned all clinical research involving germline genome editing under a newly released ethics guideline.
Germline gene engineering relates to altering the DNA in sperm, eggs or early embryos to introduce changes that can be inherited.
“Any clinical research...